Search by Drug Name or NDC
NDC 00093-2165-68 Naloxone Hydrochloride 4 mg/.1mL Details
Naloxone Hydrochloride 4 mg/.1mL
Naloxone Hydrochloride is a NASAL SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is NALOXONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Naloxone nasal spray is used along with emergency medical treatment to reverse the life-threatening effects of a known or suspected opiate (narcotic) overdose in adults and children. Naloxone nasal spray is in a class of medications called opiate antagonists. It works by blocking the effects of opiates to relieve dangerous symptoms caused by high levels of opiates in the blood.
Related Packages: 00093-2165-68Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Naloxone Nasal Spray
Product Information
| NDC | 00093-2165 |
|---|---|
| Product ID | 0093-2165_1712fc1d-aff1-4bd4-8f26-789fd7591786 |
| Associated GPIs | 93400020100920 |
| GCN Sequence Number | 075222 |
| GCN Sequence Number Description | naloxone HCl SPRAY 4 MG NASAL |
| HIC3 | H3T |
| HIC3 Description | OPIOID ANTAGONISTS |
| GCN | 40233 |
| HICL Sequence Number | 001874 |
| HICL Sequence Number Description | NALOXONE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Naloxone Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Naloxone Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY, METERED |
| Route | NASAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/.1mL |
| Substance Name | NALOXONE HYDROCHLORIDE |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Pharmaceutical Class | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209522 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00093-2165-68 (00093216568)
| NDC Package Code | 0093-2165-68 |
|---|---|
| Billing NDC | 00093216568 |
| Package | 2 BLISTER PACK in 1 CARTON (0093-2165-68) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK (0093-2165-19) / .1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2021-12-22 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 40.6426 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | NALOXONE HCL 4 MG NASAL SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis